Candida Haemulonii : An Emerging Pathogen in Immunocompromised Patient Showing Resistance to Azoles and Susceptibily to Echinocandins.

ABSTRACT

Emergence of a new species of non-albicans Candida species in Immunocompromised patient is a very alarming and life threatening trend. Accurate identification and prompt treatment in such patients is necessary to curtail mortality. Candida haemulonii as the name suggests is mostly isolated from blood culture. Susceptibility pattern of such isolates is important as most of them are not susceptible to the commonly used azole group of drugs rather they are susceptible to newer drugs like echinocandins. In such patient automated blood culture and susceptibility should be preferred over conventional blood culture so that early diagnosis and treatment can to some extent decrease the percentage of mortality.